SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Aptevo Therapeutics Q3 2026 Net Loss Narrows 13% Year Over Year to $6.5 Million

Aptevo Therapeutics Q3 2026 Net Loss Narrows 13% Year Over Year to $6.5 Million Aptevo Therapeut

APVO

Related stories